APA

Salzer W. L., Burke M. J., Devidas M., Chen S., Gore L., Larsen E. C., Borowitz M., Wood B., Heerema N. A., Carroll A. J., Hilden J. M., Loh M. L., Raetz E. A., Winick N. J., Carroll W. L. & Hunger S. P. (20190822). Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. : Cancer.

Chicago

Salzer Wanda L, Burke Michael J, Devidas Meenakshi, Chen Si, Gore Lia, Larsen Eric C, Borowitz Michael, Wood Brent, Heerema Nyla A, Carroll Andrew J, Hilden Joanne M, Loh Mignon L, Raetz Elizabeth A, Winick Naomi J, Carroll William L and Hunger Stephen P. 20190822. Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. : Cancer.

Harvard

Salzer W. L., Burke M. J., Devidas M., Chen S., Gore L., Larsen E. C., Borowitz M., Wood B., Heerema N. A., Carroll A. J., Hilden J. M., Loh M. L., Raetz E. A., Winick N. J., Carroll W. L. and Hunger S. P. (20190822). Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. : Cancer.

MLA

Salzer Wanda L, Burke Michael J, Devidas Meenakshi, Chen Si, Gore Lia, Larsen Eric C, Borowitz Michael, Wood Brent, Heerema Nyla A, Carroll Andrew J, Hilden Joanne M, Loh Mignon L, Raetz Elizabeth A, Winick Naomi J, Carroll William L and Hunger Stephen P. Toxicity associated with intensive postinduction therapy incorporating clofarabine in the very high-risk stratum of patients with newly diagnosed high-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group study AALL1131. : Cancer. 20190822.